Skip to main content
Log in

Surgical Outcomes of Rectal Gastrointestinal Stromal Tumor in the Era of Imatinib

  • Research Communication
  • Published:
Journal of Gastrointestinal Surgery

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Kameyama H, Kanda T, Tajima Y, Shimada Y, Ichikawa H, Hanyu T, et al. Management of rectal gastrointestinal stromal tumor. Translational gastroenterology and hepatology. 2018;3:8.

    Article  Google Scholar 

  2. Cavnar MJ, Wang L, Balachandran VP, Antonescu CR, Tap WD, Keohan M, et al. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome. Ann Surg Oncol. 2017;24(13):3972-80.

    Article  Google Scholar 

  3. Hohenberger P, Eisenberg B. Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST). Ann Surg Oncol. 2010;17(10):2585-600.

    Article  Google Scholar 

  4. Sun Q, Su N, Li X, Hu Z, Wang W. Open transanal resection of low rectal stromal tumor following neoadjuvant therapy of imatinib mesylate: Report of 11 cases and review of literature. Asia Pac J Clin Oncol. 2020;16(3):123-8.

    Article  Google Scholar 

  5. Fujimoto Y, Akiyoshi T, Konishi T, Nagayama S, Fukunaga Y, Ueno M. Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum. Int J Colorectal Dis. 2014;29(1):111-6.

    Article  Google Scholar 

  6. Akiyoshi T, Ueno M, Fukunaga Y, Nagayama S, Fujimoto Y, Konishi T, et al. Laparoscopic local excision and rectoanal anastomosis for rectal gastrointestinal stromal tumor: modified laparoscopic intersphincteric resection technique. Dis Colon Rectum. 2014;57(7):900-4.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Jane Charbonneau, DVM and Angela Morben, DVM, ELS, from Edanz Group (https://en-author-services.edanz.com/ac), for editing a draft of this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

SE and TA designed the study and wrote the manuscript. All authors contributed to the analysis and interpretation of the data. All authors critically reviewed the manuscript and approved the final version of the manuscript.

Corresponding author

Correspondence to Takashi Akiyoshi.

Ethics declarations

Ethical Approval

This study was approved by the Ethical Committee of the Cancer Institute Hospital of the Japanese Foundation for Cancer Research (#2019-1119).

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Address where the work was performed

Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 135-8550, Japan

Tel: +81-3-3520-0111, Fax: +81-3-3520-0141

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Emoto, S., Akiyoshi, T., Mukai, T. et al. Surgical Outcomes of Rectal Gastrointestinal Stromal Tumor in the Era of Imatinib. J Gastrointest Surg 25, 2963–2965 (2021). https://doi.org/10.1007/s11605-021-05017-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-021-05017-x

Keywords

Navigation